Previous 10 | Next 10 |
Summary Gossamer's TORREY showed stat sig PVR improvement, but the 6MWD was under what investors were hoping for; this led to a +70% decline in share price. Seralutnib is entering phase 3 with an adapted design (with more severe patients); although the success is less clear, any positiv...
Summary The popular dividend ETF SCHD is less defensive than it seems. Headwinds in the top industries in SCHD suggest a future with an ample amount of headwinds. Technical analysis suggests the tide is turning for SCHD, with underperformance vs S&P 500 following almost 2 years ...
Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...
Summary Healthcare is considered a defensive sector and due to the brand name and cheap exposure, Vanguard's ETF prima-facie looks like a promising idea. However, outsized exposure to pharmaceuticals and biotechnology makes VHT a high beta healthcare ETF, undermining its defensive quali...
Summary Last year’s market volatility was driven primarily by uncertainty over inflation and interest rates. In last year’s downturn, technology stocks were at the epicenter of market volatility. After years of steady gains, investors now acknowledge that technology stocks...
Summary An aging population is expected to boost the demand for healthcare over the next few decades. The potential to reduce time and cost using AI in healthcare is an absolute game changer for the industry. Demographics and technology provide a compelling long-term case for portfo...
Summary The health care sector - as measured by the Fidelity Health Care ETF - outperformed the S&P 500 by ~12.2% over the past year. That's because health care is considered to be a relatively defensive sector due to the fact that healthcare - in general - cannot be delayed, no mat...
Summary Healthcare stocks have remained in vogue through volatile markets, driven by increased interest in the sector during COVID-19. During a painful year for equity investors in 2022, healthcare stocks offered a pocket of relative stability. Global healthcare stocks ended the yea...
Summary How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector. How staff shortages in the health care sector may also impact investors. Health care managed to outperform the S&P 500 last yea...
Summary The first few months of 2023 could see stocks fall 10% to 23%, and a lot of investors could make disastrous mistakes. Low-volatility high-yield blue-chips are a great way to stay invested and profit from the coming new bull market. These are the 9 best high-yield blue-chips ...
News, Short Squeeze, Breakout and More Instantly...
Vanguard Health Care Company Name:
VHT Stock Symbol:
NYSE Market:
2024-07-05 08:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-25 10:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-15 11:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...